1. Home
  2. NICE guidance
  3. In development

Idelalisib with bendamustine and rituximab for previously treated chronic lymphocytic leukaemia [ID839]

In development [GID-TA10109] Expected publication date: TBC

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Invitation to participate

  • Final scope PDF 219 KB 03 May 2017  
  • Final matrix PDF 261 KB 03 May 2017